Clinical Trial Update: mFOLFOXIRI Compared to mFOLFOX6 or CapeOx as Adjuvant Chemotherapy for Stage IIIB or IIIC Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing mFOLFOXIRI with mFOLFOX6 or CapeOx as adjuvant chemotherapy for stage IIIB/IIIC colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CAPEOX
• MFOLFOX6
• MFOLFOXIRI

Snippet

Sponsor: First Affiliated Hospital of Wenzhou Medical University | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN